ImmunityBio, Inc. — Director's Dealing 2018

Nov 15, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NantKwest, Inc. (NK)
CIK: 0001326110
Period of Report: 2018-11-12

Reporting Person: GORLIN STEVE (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-11-12	Common Stock	S	47050	$2.4328	Disposed	149230	Direct
2018-11-13	Common Stock	S	33300	$2.399	Disposed	115930	Direct
2018-11-14	Common Stock	S	115930	$2.2058	Disposed	0	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	321720	Indirect

Footnotes

F1: Represents the weighted average share price of an aggregate total of 47,050 shares sold in the price range of $2.40 to $2.62 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F2: Represents the weighted average share price of an aggregate total of 33,300 shares sold in the price range of $2.38 to $2.47 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F3: Represents the weighted average share price of an aggregate total of 115,930 shares sold in the price range of $2.17 to $2.40 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.